It should be noted, however, that the treatment-related patterns of cytokine concentrations in the brain do not match with the patterns of plasma cytokine concentrations and other markers of colitis (MPO, DAS), suggesting a central effect of WAS to promote neuroinflammation. This evidence concerns the gene MPO and colitis.